Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries
نویسندگان
چکیده
Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries Joost Swart, Alessandro Consolaro, Gerd Horneff, BIKER, Kimme L Hyrich, UK BCRD Study Group and BSPAR Etanercept Study Group, Francesca Bovis, Jose Melo-Gomes, Ekaterina Alexeeva, Stefano Lanni, Gerd Ganser, Violeta Panaviene, Jordi Anton, Ivan Foeldvari, Valda Stanevicha, Susan Nielsen, Ralf Trauzeddel, Constantin Ailioaie, Pierre Quartier, Toni Hospach, Gordana Susic, Maria Trachana, Frank Weller-Heinemann, Alberto Martini, Nico Wulffraat, Nicolino Ruperto
منابع مشابه
Adverse events of methotrexate treatment in JIA
Background Methotrexate (MTX) which has been used for 20 years in Juvenile Idiopathic Arthritis (JIA) has now become the first-choice, second-line agent for children with polyarticular course JIA. New biologic drugs are used for MTX-failing patients and have been assessed in controlled trials for effectiveness. Safety data of these drugs are slowly and selectively emerging as post-marketing dat...
متن کاملWhat are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
This review summarizes the immunological consequences of biological therapies used in juvenile idiopathic arthritis (JIA). For every frequently used biological agent the characteristics are clearly specified (molecular target, isotype, registered indication for JIA, route of administration, half-life, contraindication, very common side effects, expected time of response and average cost in the ...
متن کاملMulticentric Carpotarsal Osteolysis Mimicking Juvenile Idiopathic Arthritis
Background Multicentric carpotarsal osteolysis (MCTO), a skeletal dysplasia presents in early childhood mimicking juvenile idiopathic arthritis (JIA). Recognition of this syndrome is essential to avoid unnecessary treatment with immunosuppressive agents because of different course and treatment. Case Report A 3-year-old boy presented with swelling and restriction of right wrist joint and left ...
متن کاملInformation technology in paediatric rheumatology.
Information technology in paediatric rheumatology has seen several exciting developments in recent years. The new multidimensional questionnaires for juvenile idiopathic arthritis, juvenile dermatomyositis, and juvenile autoinflammatory diseases integrate all major parent- and child-reported outcomes (PCROs) used in these diseases into a single tool, and provide an effective guide to manage, do...
متن کاملBaseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation
BACKGROUND The anti-TNF inhibitor, etanercept is administered as a once or twice weekly subcutaneous injection for the treatment of rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis (JIA). Limited data from the patients' perspective are available on the use of biologics in the treatment of these chronic conditions and this evaluation ...
متن کامل